Search research articles
Contact Us
Filters
Showing results (1-10 of 82) with videos related to
Page
of 9
Sort By:
Expert Opinion on Investigational Drugs
|
October 21, 2017
Vedroprevir in the management of hepatitis C virus infection
Ameer Abutaleb, Shyamasundaran Kottilil
JAMA
|
July 21, 2011
Hepatitis C virus infection and coinfection with human immunodeficiency virus: challenges and advancements in management
Colleen Hadigan, Shyamasundaran Kottilil
Frontiers in Medicine
|
August 22, 2022
Immunomodulatory therapies for COVID-19
Poonam Mathur, Shyamasundaran Kottilil
Hepatology International
|
September 15, 2016
Elbasvir/grazoprevir for treatment of chronic hepatitis C virus infection
Chandana Papudesu, Shyamasundaran Kottilil, Shashwatee Bagchi
Hepatology International
|
January 2, 2017
Erratum to: Elbasvir/grazoprevir for treatment of chronic hepatitis C virus infection
Chandana Papudesu, Shyamasundaran Kottilil, Shashwatee Bagchi
Scientific Reports
|
November 17, 2020
Reconstitution of T follicular helper-humoral immune axis with elimination of hepatitis C virus
Arshi Khanam, Shyamasundaran Kottilil, Eleanor Wilson
Antiviral Therapy
|
September 14, 2018
Sofosbuvir/velpatasvir/voxilaprevir: a highly effective option for retreatment of hepatitis C in difficult-to-treat patients
Poonam Mathur, Shyamasundaran Kottilil, Eleanor Wilson
Journal of Clinical and Translational Hepatology
|
January 15, 2019
Use of Ribavirin for Hepatitis C Treatment in the Modern Direct-acting Antiviral Era
Poonam Mathur, Shyamasundaran Kottilil, Eleanor Wilson
Future Microbiology
|
August 6, 2024
Fighting fire with fire: using infectious agents to treat persistent infection
Maha Albukhari, Maria Bagies, Tanya Lizbeth, et al.
Future Virology
|
October 30, 2012
Opportunities in proteomics to understand hepatitis C and HIV coinfection
Eric G Meissner, Anthony F Suffredini, Shyamasundaran Kottilil
Page
of 9
Search research articles
Search
Showing results (1-10 of 82) with videos related to
Sort By:
Page
of 9
Expert Opinion on Investigational Drugs
|
October 21, 2017
Vedroprevir in the management of hepatitis C virus infection
Ameer Abutaleb, Shyamasundaran Kottilil
JAMA
|
July 21, 2011
Hepatitis C virus infection and coinfection with human immunodeficiency virus: challenges and advancements in management
Colleen Hadigan, Shyamasundaran Kottilil
Frontiers in Medicine
|
August 22, 2022
Immunomodulatory therapies for COVID-19
Poonam Mathur, Shyamasundaran Kottilil
Hepatology International
|
September 15, 2016
Elbasvir/grazoprevir for treatment of chronic hepatitis C virus infection
Chandana Papudesu, Shyamasundaran Kottilil, Shashwatee Bagchi
Hepatology International
|
January 2, 2017
Erratum to: Elbasvir/grazoprevir for treatment of chronic hepatitis C virus infection
Chandana Papudesu, Shyamasundaran Kottilil, Shashwatee Bagchi
Scientific Reports
|
November 17, 2020
Reconstitution of T follicular helper-humoral immune axis with elimination of hepatitis C virus
Arshi Khanam, Shyamasundaran Kottilil, Eleanor Wilson
Antiviral Therapy
|
September 14, 2018
Sofosbuvir/velpatasvir/voxilaprevir: a highly effective option for retreatment of hepatitis C in difficult-to-treat patients
Poonam Mathur, Shyamasundaran Kottilil, Eleanor Wilson
Journal of Clinical and Translational Hepatology
|
January 15, 2019
Use of Ribavirin for Hepatitis C Treatment in the Modern Direct-acting Antiviral Era
Poonam Mathur, Shyamasundaran Kottilil, Eleanor Wilson
Future Microbiology
|
August 6, 2024
Fighting fire with fire: using infectious agents to treat persistent infection
Maha Albukhari, Maria Bagies, Tanya Lizbeth, et al.
Future Virology
|
October 30, 2012
Opportunities in proteomics to understand hepatitis C and HIV coinfection
Eric G Meissner, Anthony F Suffredini, Shyamasundaran Kottilil
Page
of 9